MATERIALS AND METHODS. We evaluated 35 bronchioloalveolar carcinomas and 17 atypical adenomatous hyperplasias that were histologically confirmed and that manifested pure GGO on thin-section helical CT scans. We recorded the age, sex, and smoking history (Brinkman index) of the patients. Two board-certified radiologists measured the maximum diameter and mean attenuation value of the nodules; the measured values were averaged for each nodule. Using a 3-point scale, they visually assessed the images for consensus with respect to nodular sphericity, marginal irregularity, vascular convergence, pleural retraction, and findings of an internal air bronchogram. CT findings of atypical adenomatous hyperplasia and bronchioloalveolar carcinoma were compared using univariate and multivariate logistic regression analysis; the odds ratio was computed using the atypical adenomatous hyperplasia group as the reference group.

RESULTS. By univariate analysis, the patient age, nodular maximum diameter, mean attenuation value, and findings of an internal air bronchogram were statistically significantly associated with bronchioloalveolar carcinoma (odds ratio [OR] = 1.10 [p = 0.012], OR = 1.27 [p < 0.01], OR = 1.01 [p = 0.023], and OR = 25.30 [p < 0.001], respectively), and sphericity was significantly associated with atypical adenomatous hyperplasia (OR = 0.059, p < 0.001). By multivariate analysis, sphericity was significantly associated with atypical adenomatous hyperplasia (OR = 0.125, p = 0.042) and findings of an internal air bronchogram were associated with bronchioloalveolar carcinoma (OR = 16.10, p = 0.007).

CONCLUSION. Nodular sphericity and an internal air bronchogram were useful at thin-section helical CT performed to differentiate between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia. Interobserver agreement was high for each finding.

SUBJECTS AND METHODS. The subjects were 26 patients (10 men, 16 women; mean age, 57 ± 9 [SD] years; 16 with nonspecific interstitial pneumonia; 10 with usual interstitial pneumonia) who underwent 3-T MRI of the lung and surgical biopsy. A total of 54 biopsy sites were classified histopathologically into two groups: inflammation predominant and fibrosis predominant. After a T2-weighted triple-inversion black blood turbo spin-echo (TSE) sequence, dynamic MRI was performed with a T1-weighted 3D turbo field-echo sequence (coronal images with 2.5-mm slice thickness) before and 1, 3, 5, and 10 minutes after IV contrast injection. The chi-square test was used to compare differences in signal intensity on T2-weighted triple-inversion black blood TSE MR images and visually assessed enhancement patterns at dynamic MRI for the inflammation- and fibrosis-predominant sites.

RESULTS. Inflammation-predominant specimens were obtained from 31% (17 of 54) of the biopsy sites. Inflammation-predominant biopsy sites had an early enhancement pattern (82%, 14 of 17 sites, p < 0.001) on dynamic studies and high signal intensity (53%, nine of 17 sites, p = 0.001) on T2-weighted triple-inversion black blood TSE images.

CONCLUSION. Multiphase dynamic enhancement studies with a turbo field-echo sequence and T2-weighted triple-inversion black blood TSE images on 3-T MRI appear to be useful for differentiating inflammation- and fibrosis-predominant lesions.

MATERIALS AND METHODS. Dual-energy subtraction chest radiographs of 19 patients with previously missed nodular cancers, in which the radiology report did not mention a nodule that was visible in retrospect, were selected. Dual-energy subtraction radiographs of 19 patients with cancer and 16 patients without cancer were used for an observer study. Six radiologists indicated their confidence level regarding the presence of a lung cancer and, if they thought a cancer was present, also marked the most likely position for each lung, first using standard posteroanterior and lateral chest radiographs and then using both soft-tissue and bone dual-energy subtraction images along with standard radiographs. Receiver operating characteristic (ROC) curves were used to evaluate the observers' performance. The indicated locations of cancers and false-positives were also analyzed.

RESULTS. The average area under the ROC curve (A_z) value for the six radiologists was improved from 0.718 to 0.816, a statistically significant amount (p = 0.004), and the average sensitivity (correct localizations) for 19 previously missed cancers was also significantly improved from 40% to 59% (p = 0.008) with the aid of dual-energy subtraction images. The average number of false-positive (incorrect) localizations on 70 lungs was 10 without and nine with dual-energy subtraction images (p = 0.785).

CONCLUSION. Dual-energy subtraction chest radiography has the potential to improve radiologists' performance for the detection of small missed lung cancers.

MATERIALS AND METHODS. Two hundred three consecutive subjects (patients with diagnosed HHT or first-degree relatives; 87 males, 116 females; 6–83 years old) underwent pulmonary CE-MRA with 0.1 mmol/kg of gadobenate dimeglumine. The presence of pulmonary AVM was scored as 0 (none present), 1 (definitely present), or 2 (uncertain) and was evaluated by patient sex and pulmonary AVM size (< 5, 5–10, 11–15, 16–20, > 20 mm). Patients scored as 1 or 2 with at least one pulmonary AVM of ≥ 5 mm underwent conventional pulmonary angiography for possible embolization. Pulmonary AVM detection on CE-MRA and pulmonary angiography was compared using paired Student's t tests.

RESULTS. The presence of pulmonary AVM was considered definite in 56 of 203 (27.6%) patients and uncertain in one of 203 patients on CE-MRA. Of 156 pulmonary AVMs detected on CE-MRA, 124 (49 in 27 males, 75 in 30 females) were detected on first screening CE-MRA and 32 on follow-up CE-MRA. Pulmonary AVMs on CE-MRA were solitary in 25 patients, multiple in 31 patients, and predominantly small (< 5 mm, n = 32; 5–10 mm, n = 45). Significantly (p < 0.0001) fewer pulmonary AVMs were detected on pulmonary angiography (76/96 [79.2%] evaluable pulmonary AVMs in 40 patients before first pulmonary angiography; 92/119 [77.3%] pulmonary AVMs overall). Three-dimensional maximum-intensity-projection reconstructions permitted improved pulmonary AVM visualization and embolization planning of complex pulmonary AVMs.

CONCLUSION. CE-MRA is suitable for screening patients with HHT. It permits accurate detection and staging of pulmonary AVMs, appropriate differentiation of lesions requiring embolization and accurate orientation, and visualization and planning of embolization therapy.

MATERIALS AND METHODS. MRA examinations of the thoracic aorta were retrospectively reviewed in 23 patients in whom both CE-MRA and 3D SSFP were performed. CE-MRA was performed using an ECG-gated gradient-echo FLASH sequence. Three-dimensional SSFP MRA was performed during free breathing using a motion-adaptive navigator technique. Quantitative assessment of the 3D SSFP and CE-MRA image sets was performed by comparing the aortic lumen diameter. The quality of the images of the aortic root (scale of 1–5) and the presence of cardiovascular and noncardiovascular pathology were independently determined for both techniques by two reviewers. Bland-Altman and Wilcoxon's signed-rank analyses were performed.

RESULTS. The difference in orthogonal measurements of the aortic diameter between those made on images from the 3D SSFP and those made from the CE-MRA sequences was –0.042 cm. The aortic root was better visualized with 3D SSFP: score of 3.78 (of 5) for CE-MRA versus score of 4.65 (of 5) for 3D SSFP (p < 0.05).

CONCLUSION. In patients in whom contrast material is contraindicated, unenhanced MRA using a 3D SSFP technique can be performed.

CONCLUSION. MDCT allows us to diagnose a full spectrum of disease processes associated with aspiration and complications in the airways and lung. Recognition of the CT findings characteristic of a specific type and location of the aspirate is valuable to make an accurate diagnosis, thereby facilitating optimal clinical management.

CONCLUSION. Superimposition of the scapula on the upper thoracic spine causes a vertebral pseudolesion that simulates a sclerotic lesion.